omicron variant. this new drug can be used to treat mild to moderate cases in patients as young as 12 years old. let's bring in an msnbc contributor and founding director of the national center for disaster preparedness at columbia university. welcome, sir, it's good to see you. as i start with your reaction to pfizer rolling back their request for the fda to approve their covid vaccine for kids under the age of 5. what do you think's behind that? >> yeah, hi, alex. sorry, i think my picture's a little frozen here. but here's the point. this is a little bit of, you know, vaccine drama here. we have pfizer out of the blue repealing, pulling back their request to the fda to get this emergency approval for vaccine for children under the age of 4 and under. and this is a problem because many parents were expecting to be able to get their young children protected by as early as next week, and now we probably won't see that approval coming before april.
Related Keywords
Director , Msnbc , Contributor , Cases , Drug , Disaster Preparedness , Patients , Center , Omicron Variant , 12 , Alex , Age , Kids , Pfizer , Request , Covid , Vaccine , Reaction , Hi , Fda , Sir , Picture , Columbia University , 5 , Bit , Little , Emergency Approval , Repealing , The Point , Vaccine Drama , Out Of The Blue , Children , Problem , Parents , Approval , Under , 4 ,
comparemela.com © 2020. All Rights Reserved.